Castle Biosciences, Inc. Common Stock

CSTLNASDAQ • USD
33.79 USD
↘ 0.01 (0.01%)🟢PRE MARKET (AS OF 03:59 AM EST)
🟢Market: OPEN

Castle Biosciences, Inc. Common Stock (CSTL) is currently trading at $33.79. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest CSTL is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 13, 2026.

Open?$33.79
High?$33.79
Low?$33.79
Prev. Close?$33.79
Volume?0
Avg. Volume?404.4K
Bid / Ask
Bid?$29.10 × 100
Ask?$38.33 × 100
Spread?$9.23
Midpoint?$33.72
Valuation & Ratios
Market Cap?1.0B
Shares Out?30.8M
Float?28.6M
Float %?93.5%
P/E Ratio?N/A
P/B Ratio?2.18
EPS?-$0.75
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Employees
1.0K
Market Cap
1.0B
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2019-07-25
Address
1500 W. PARKWOOD AVE.
FRIENDSWOOD, TX 77546
Phone: 866-788-9007
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
100
Momentum?
18
Short Sent.?
54
Piotroski F-Score?2/9Weak
Altman Z-Score?12.40Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?7.39%Elevated
Short Interest?2.1M
Days to Cover?6.1
Free Float28.6M
Avg Daily Volume347.9K
Settlement Date2026-10-30
Financial Health
Current Ratio?5.28Strong
Quick Ratio?5.12Strong
Cash Ratio?1.15Strong
Debt/Equity?0.02Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
87/100
P/E?
N/A▾
P/B?
Peers
100
S&P
70
2.18CHEAP▾
P/S?
Peers
100
S&P
54
2.76CHEAP▾
P/FCF?
Peers
100
S&P
3
262.8PRICEY▾
EV/EBITDA?
S&P
97
-80.6CHEAP▾
EV/Sales?
Peers
100
S&P
67
2.58CHEAP▾
Returns & Efficiency
ROE?
S&P
11
-4.8%WEAK▾
ROA?
S&P
3
-4.0%WEAK▾
Cash Flow & Enterprise
FCF?$4.0M
Enterprise Value?$973.7M
Fundamentals ratios updated end of day